Johnson & Johnson (NYSE: JNJ)‘s stock had its “buy” rating restated by stock analysts at Deutsche Bank in a report issued on Tuesday, AnalystRatingsNetwork.com reports. They currently have a $92.00 price target on the stock. Deutsche Bank’s price target indicates a potential upside of 1.77% from the stock’s previous close.
Johnson & Johnson (NYSE: JNJ) opened at 90.40 on Tuesday. Johnson & Johnson has a 52-week low of $66.85 and a 52-week high of $90.81. The stock’s 50-day moving average is currently $86.04. The company has a market cap of $253.9 billion and a price-to-earnings ratio of 24.55.
Johnson & Johnson (NYSE: JNJ) last announced its earnings results on Tuesday, July 16th. The company reported $1.48 earnings per share for the quarter, beating the analysts’ consensus estimate of $1.39 by $0.09. The company had revenue of $17.90 billion for the quarter, compared to the consensus estimate of $17.71 billion. During the same quarter last year, the company posted $1.30 earnings per share. Johnson & Johnson’s revenue was up 8.5% compared to the same quarter last year. Johnson & Johnson has set its FY13 guidance at $5.40-5.47 EPS. On average, analysts predict that Johnson & Johnson will post $5.41 earnings per share for the current fiscal year.
Other equities research analysts have also recently issued reports about the stock. Analysts at Barclays Capital reiterated an “overweight” rating on shares of Johnson & Johnson in a research note to investors on Tuesday, July 9th. They now have a $95.00 price target on the stock. Separately, analysts at Jefferies Group reiterated a “hold” rating on shares of Johnson & Johnson in a research note to investors on Monday, July 8th. They now have a $91.00 price target on the stock. Finally, analysts at Argus raised their price target on shares of Johnson & Johnson from $80.00 to $96.00 in a research note to investors on Monday, July 8th. They now have a “buy” rating on the stock.
Three analysts have rated the stock with a sell rating, six have given a hold rating and nine have given a buy rating to the company. Johnson & Johnson has an average rating of “Hold” and an average price target of $84.75.
The company also recently announced a quarterly dividend, which is scheduled for Tuesday, September 10th. Shareholders of record on Tuesday, August 27th will be paid a dividend of $0.66 per share. This represents a $2.64 annualized dividend and a dividend yield of 2.92%. The ex-dividend date is Friday, August 23rd.
Johnson & Johnson is a holding company. The Company is engaged in the research and development, manufacture and sale of a broad range of products in the health care field.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.